RECRUITING

Optimizing Engagement in Services for First-Episode Psychosis

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will compare a 12-session behavioral activation (BA) intervention modified for first-episode psychosis (FEP) to usual community mental health care (i.e., treatment-as-usual; TAU) delivered over 6 months with a sample of Latinos with FEP and their families. Comparable family group sessions will also be delivered to participants in both conditions. It is expected that BA participants will show better engagement than TAU participants.

Official Title

Optimizing Engagement in Services for First-Episode Psychosis (FEP) in the Community Mental Health Setting

Quick Facts

Study Start:2022-03-01
Study Completion:2026-02-28
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05310838

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:15 Years to 35 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Self-identification as Latino
  2. * Age 15 to 35
  3. * Diagnostic \& Statistical Manual of Mental Disorders-5 diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, other specified schizophrenia spectrum, affective psychosis, and other psychotic disorder criteria
  4. * Ability to speak English or Spanish
  5. * Caregiver willing to consent to participate in the study and care
  6. * Ability to provide fully informed consent
  1. * Diagnosis of psychotic disorder due to another medical condition or substance/medication-induced psychotic disorder
  2. * Presence of a serious medical condition
  3. * 3≤ years after the onset

Contacts and Locations

Study Contact

Maria Santos, PhD
CONTACT
909-537-4507
Maria.Santos@csusb.edu

Principal Investigator

Maria Santos, PhD
PRINCIPAL_INVESTIGATOR
California State University, San Bernardino

Study Locations (Sites)

San Fernando Mental Health Center
Granada Hills, California, 91344
United States
Olive View - UCLA Medical Center
Sylmar, California, 91342
United States

Collaborators and Investigators

Sponsor: California State University, San Bernardino

  • Maria Santos, PhD, PRINCIPAL_INVESTIGATOR, California State University, San Bernardino

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-03-01
Study Completion Date2026-02-28

Study Record Updates

Study Start Date2022-03-01
Study Completion Date2026-02-28

Terms related to this study

Keywords Provided by Researchers

  • First Episode Psychosis
  • Behavioral Activation
  • Engagement
  • Latinx

Additional Relevant MeSH Terms

  • Engagement, Patient
  • First Episode Psychosis